Then why invest?
Thanks for your reply, but it doesn't answer the question.
Why is the company using 2005 paper (Hegi) doe Tem data, when as per my post above there are many other more recent papers? There is proba good reason, and I would like to know what it is.
These are genuine queries, and if they don't have good evidenced answers, the investment thesis here is in question for me.
GLTA.
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia releases final data from P2 paxalisib trial
Ann: Kazia releases final data from P2 paxalisib trial, page-101
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online